P-161: Oral antivirals ritonavir-nirmatrelvir and molnupiravir are highly effective in patients with multiple myeloma and COVID-19; a singlecenter, prospective study

Detalles Bibliográficos
Autores principales: Spiliopoulou, Vassiliki, Ntanasis-Stathopoulos, Ioannis, Malandrakis, Panagiotis, Gavriatopoulou, Maria, Theodorakakou, Foteini, Fotiou, Despina, Migkou, Magdalini, Roussou, Maria, Eleutherakis-Papaiakovou, Evangelos, Kastritis, Efstathios, Dimopoulos, Meletios A., Terpos, Evangelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Poster Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403043/
http://dx.doi.org/10.1016/S2152-2650(22)00491-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403043/
http://dx.doi.org/10.1016/S2152-2650(22)00491-8

Ejemplares similares